The recent approval of Regeneron’s Otarmeni underscores the maturation of gene therapies across a range of diseases. Here, ...
Radiation ±cisplatin for bulky stage IB cervical carcinoma; Long-term follow-up of a GOG trial No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2006 ASCO ...
VEGF or vascular endothelial growth factor is a signalling protein made by cells that stimulates the formation of new blood vessels. There are several different classes of VEGF that play different ...
Please provide your email address to receive an email when new articles are posted on . In this Healio Video Perspective from the Retina Society meeting, Sumit Sharma, MD, of Cole Eye Institute ...
This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...
VEGF (vascular endothelial growth factor) is a signal protein that promotes the growth of new blood vessels. VEGF forms part of the system that restores the blood supply to cells and tissues when they ...
Anti-VEGF injections are a common and effective treatment for wet age-related macular degeneration (AMD). By targeting and eliminating abnormal blood vessels in the retina, they can help prevent ...
A phase I study of the novel molecularly targeted vascular targeting agent, Exherin (ADH-1), shows activity in some patients with refractory solid tumors stratified according to N-cadherin expression ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results